RAHWAY, N.J. & NUTLEY, N.J., January 24, 2025--Merck and Eisai ... a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for ...
Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback